Call for Poster Abstract Submissions
The 2nd Doha-Heidelberg Clinical & Research Conference will once again bring together clinicians, scientists, researchers and other stakeholders from both organizations to exchange knowledge and explore clinical and research collaborations.
The focus of the second conference will be oncology, with particular focus on Breast Cancer, Uro-Oncology Head & Neck cancers, and Rare Diseases to include rare skin cancers, and genomics, as well as a review of new imaging techniques.
We invite poster abstracts related to these topics or pertinent to the care and management of cancer patients in these disease groups.
Abstract submission opens: 20th November 2018 and closes: 11pm on 15th December 2018
You should receive a confirmatory response. Please contact us if you do not receive a reply.
Information for Abstract Submission
- All abstracts must be submitted using the official conference poster abstract submission process.
- There is no limit to the number of abstracts for posters an author may submit.
- Abstract submissions on cancer research should be for research that is either complete or will be completed no later than the date of the conference.
- The Poster Committee will review the poster for relevance, validity, originality, special merit or other considerations
- Submitting authors for those poster abstracts that are accepted will be informed of the date and time of the poster judging sessions.
- Notification of Poster Acceptance will be communicated by 16th December 2018
If you have any queries about submitting an abstract, please contact Niloofar
Phone: (974) 44398595
Mobile (974)66050199
